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teins, and brain natriuretic peptide (BNP) levels. Glomerular ﬁltration
rate (GFR) was estimated with the CKD-EPI Creatinine Equation.
Spearman's rank correlation tests were conducted to assess relation-
ships between nonparametric variables, and multiple regression analy-
ses were performed to exclude multicollinearity. Data were analyzed
with JMP 12 software (SAS Institute, Inc., Cary, NC).
Patient characteristics are summarized in Table 1. The estimated sys-
tolic pulmonary artery pressure (ePAP) and BNP levelswere 82.7±15.7
(mean ± SD) mm Hg and 176 ± 146 ng/L, respectively. LV diastolic
diameter (LVDd) was negatively correlated with ePAP (rs = −0.76,Cachexia is associated with a high risk of death in heart failure (HF)
patients [1,2]. Right ventricular dysfunction (RVD) reportedly often
coexists with cachexia and is associated with accelerated weight loss,
abnormal body composition, and a worsened prognosis in advanced
HF [3]. Multiple mechanisms are thought to be involved in the develop-
ment of cardiac cachexia. In particular, this condition is related to hemo-
dynamics of HF including pulmonary hypertension [4] as well as
increased neurohumoral and cytokine responses [5,6], impaired gastro-
intestinal function [7], and an increased metabolic rate [8].
However, only a few studies have investigated pulmonary arterial
hypertension (PAH) and nutritional status [9]. In the present study,
we sought to examine the relationships among nutritional status,
markers of congestion, and echocardiographic parameters in patients
with stable PAH. Findings from the present study would provide in-
sights on the mechanism underlying the effect of PAH alone on nutri-
tional status.
We enrolled 8 patients with stable (N6 months) pulmonary hyper-
tension from our out-patient clinic prospectively, and written informed
consent was obtained. The study conformed to the ethical guidelines of
the 1975 Declaration of Helsinki and was approved by the ethical com-
mittee of Kyoto University Hospital. Patients underwent the scored
Patient-Generated Subjective Global Assessment (PG-SGA) for nutri-
tional status, blood tests, and comprehensive echocardiography. After
morning fasting, patients underwent blood testing for complete bloodarMedicine, Graduate School of
kyo-ku, Kyoto 606-8507, Japan.
land Ltd. This is an open access articlcounts, chemistry, zinc, pre-albumin, transferrin, retinol-binding pro-
p = 0.04), which implied a dilated RV and compressed LV. Body mass
index (BMI) was positively correlated with white blood cell count
(WBC, rs = 0.84, p = 0.03) and fasting insulin levels (rs = −0.57,
p = 0.03) and negatively correlated with aspartate aminotransferase
concentration (AST, rs =−0.47, p = 0.02), serum sodium concentra-
tion (rs = −0.60, p = 0.03), and inferior vena cava (IVC) diameter
(rs=−0.76, p= 0.04). Blood urea nitrogen, amarker of protein catab-
olism, was positively correlated with SGA scores (rs = 0.81, p b 0.01)
and BNP (rs = 0.68, p = 0.04) and negatively correlated with LV diam-
eter (rs = −0.87, p b 0.01). Serum pre-albumin – a rapid-turnover
hepatic protein – was positively correlated with ePAP (rs = 0.70, p =
0.01) and negatively correlated with serum sodium concentrations
(rs = −0.56, p = 0.02). Fig. 1 and supplementary Fig. 1 show the
correlation map with clustering in which factors cluster more closely
together based on how closely they are associated and multiple
scattered maps with correlation coefﬁcients, respectively. In multiple
regression analyses, BMI was associated by WBC count (p = 0.008),
ePAP (P= 0.0008), serum sodium (p=0.001), and AST concentrations
(p = 0.0005), and IVC diameter (p = 0.0042; supplementary Table 1).
As previously reported [8], increased right heart ﬁlling pressure and
tricuspid regurgitation have been associated with body fat depletion
and low BMI in HF patients. RV function and degree of pulmonary hy-
pertension may play a critical role in the nutritional status in patients
with PAH by maintaining cardiac output and by possibly causing con-
gestion of splanchnic organs.
Liver congestion was estimated from the correlation between
pre-albumin and ePAP. In our study, BMI was in association with nutri-
tional factors, liver enzymes, serum sodium, ePAP, and IVC diameter,
indicating the presence of a close relationship between pulmonary hy-
pertension with IVC dilatation, poor nutritional status, and low BMI.
Valentova et al. reported that cachexia in HF patients is associatede under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Patients characteristics.
Sex Male 4 Mean ± SD Mean ± SD
Female 4 WBC (/μL) 5.6 ± 0.9 Blood sugar (mg/dL) 96.3 ± 6.3
HGB (g/dL) 14.9 ± 1.7 Na (mEq/L) 142.3 ± 2.6
Mean ± SD Lymph (/mm3) 1831 ± 622 C-reactive protein (g/dL) 0.1 ± 0.1
Age 62.4 ± 2.4 AST (IU/L) 26.5 ± 11.7 Zinc (μg/dL) 72.9 ± 4.7
BMI 22.1 ± 2.1 ALT (IU/L) 17.3 ± 8.5 Pre-albumin (mg/dL) 23.8 ± 5.6
Total protein (g/dL) 7.1 ± 0.6 RBP (mg/dL) 3.0 ± 0.8
SGA score 2.6 ± 2.5 Albumin (g/dL) 3.8 ± 0.2 Transferrin (mg/dL) 255.7 ± 28.6
Choline esterase (IU/L) 281 ± 59 HbA1c (NGSP %) 5.6 ± 0.3
LVDd (mm) 40.8 ± 5.1 Total bilirubin (mg/dL) 1.1 ± 0.6 Insulin (μU/mL) 24.7 ± 18.4
LVDs (mm) 22.6 ± 3.1 Creatinine (mg/dL) 0.8 ± 0.2 BNP (pg/mL) 176.9 ± 149.4
EF (%) 75.8 ± 5.2 eGFR 67.0 ± 7.0
TR-PG (mm Hg) 72.8 ± 15.8 BUN (mg/dL) 15.6 ± 4.1
Estimated PAP (mm Hg) 82.3 ± 15.7 Total cholesterol (mg/dL) 198 ± 15
IVC max (mm) 18.6 ± 8.1 HDL-chol (mg/dL) 58 ± 9
LDL-chol (mg/dL) 119 ± 16
Triglycerides (mg/dL) 122 ± 55
TG/HDL 2.3 ± .3
BMI: bodymass index; HbA1c: hemoglobin A1c; SGA: subjective global assessment; LVDd/s: left ventricular diastolic/systolic dimension; EF: ejection fraction; TR-PG: pressure gradient of
tricuspid regurgitation; PAP: pulmonary artery pressure; IVC: inferior vena cava;WBC: white blood cell; HGB: hemoglobin; AST: aspartate aminotransferase; ALT: alanine aminotransfer-
ase; eGFR: estimated glomerular ﬁltration rate; RBP: retinol binding protein; BNP: brain natriuretic peptide; SD, standard deviation; NGSP, National Glycohemoglobin Standardization
Program; eGFR, estimate glomerular ﬁltration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein; and TG, triglycerides.
28 A. Kawamoto et al. / International Journal of Cardiology 187 (2015) 27–28with RVD, liver markers, and albumin levels [10]. With regard to PAH,
nutritional statusmay be surrogatemarkers for PAH. Although cachexia
due to pulmonary disease was reversible after lung transplantation [9],
it is unclear whether interventions targeting nutritional status would
improve PAH or its prognosis.
The limitations of the present study are that the sample size was
small and all patients were from a single institution. Moreover, we did
not monitor the therapeutic effect on liver function sequentially nor
did we monitor body weight, and analyses of RVD were not performed
in all cases. However, the ejection fraction was maintained, and the
decrease in LV diastolic dimension might consequently suggest that
the RV compresses the LV.Fig. 1. This map showed that factors cluster more closely together based on how closely
they are associated. HbA1c: haemoglobin A1c, SGA: subjective global assessment, BUN:
blood urea nitrogen, ePAP: estimated pulmonary artery pressure, BNP: brain natriuretic
peptides, AST: Aspartate Aminotransferase, ALT: alanine aminotransferase, Na: sodium,
IVC: inferior vena cava, BMI: body mass index, WBC: white blood cell, T-chol: total
cholesterol, eGFR: estimated glomerular ﬁltration rate, LVDd: left ventricular diastolic
dimension.In conclusion, there were strong correlations among markers of
nutritional status, markers of congestion, and PAH severity. These
results suggest that poor nutritional status may be surrogate markers
for PAH severity. Further study is needed that it would be therapeutic
targets for PAH.
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